Kamtex Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.04 M
- Revenue Growth 44.34%
- Profit Growth 221.78%
- Ebitda 173.75%
- Net Worth 54.56%
- Total Assets 34.67%
About Kamtex Biotech
Kamtex Biotech Private Limited (KBPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 2013 and has a history of 11 years and 11 months. Its registered office is in Jodhpur, Rajasthan, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.04 M.
Tarun Jain, Renu Jain, and Navin Jain serve as directors at the Company.
Company Details
-
Location
Jodhpur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24119RJ2013PTC041492
-
Company No.
041492
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Feb 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Kamtex Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarun Jain
|
Director | 26-May-2018 | Current |
|
Renu Jain
|
Director | 15-Feb-2013 | Current |
|
Navin Jain
|
Director | 15-Feb-2013 | Current |
Financial Performance of Kamtex Biotech.
Kamtex Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.34% increase. The company also saw a substantial improvement in profitability, with a 221.78% increase in profit. The company's net worth Soared by an impressive increase of 54.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kamtex Biotech?
In 2023, Kamtex Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.04 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2024 | Hdfc Bank Limited | ₹6.04 M | Open |
How Many Employees Work at Kamtex Biotech?
Unlock and access historical data on people associated with Kamtex Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kamtex Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kamtex Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.